selected publications
- Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer cell. 2024 Academic Article GET IT
- Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer. Oncogene. 2023 Academic Article GET IT
- Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non-Muscle-Invasive Bladder Cancer. JCO clinical cancer informatics. 2023 Academic Article GET IT
- Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies. Frontiers in immunology. 2023 Academic Article GET IT
- Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy. Cell reports. 2021 Academic Article GET IT
-
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
Cancer immunology research.
2017
Academic Article
GET IT
Times cited: 129 -
Patient-derived tumor xenografts: transforming clinical samples into mouse models.
Cancer research.
2013
Information Resource
GET IT
Times cited: 530 -
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).
Oncotarget.
2011
Academic Article
GET IT
Times cited: 15 -
Second-generation shRNA libraries covering the mouse and human genomes.
Nature genetics.
2005
Academic Article
GET IT
Times cited: 512